NCT04135898View on ClinicalTrials.gov

A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

October 23, 2019

Primary Completion Date

March 16, 2020

Study Completion Date

March 16, 2020

Conditions
Healthy Male
Interventions
DRUG

SIBP-04

3mg/kg, infusion in 90 minutes

DRUG

Bevacizumab

3mg/kg, infusion in 90 minutes

Trial Locations (1)

Unknown

the First Affiliated Hospital of Bengbu Medical College, Bengbu

All Listed Sponsors
lead

Shanghai Institute Of Biological Products

INDUSTRY

NCT04135898 - A Study Comparing SIBP-04 and Bevacizumab in Healthy Male Subjects | Biotech Hunter | Biotech Hunter